Personality and serotonin transporter genotype interact with social context to affect immunity and viral set-point in simian immunodeficiency virus disease.
From the beginning of the AIDS epidemic, stress has been a suspected contributor to the wide variation seen in disease progression, and some evidence supports this idea. Not all individuals respond to a stressor in the same way, however, and little is known about the biological mechanisms by which variations in individuals' responses to their environment affect disease-relevant immunologic processes. Using the simian immunodeficiency virus/rhesus macaque model of AIDS, we explored how personality (Sociability) and genotype (serotonin transporter promoter) independently interact with social context (Stable or Unstable social conditions) to influence behavioral expression, plasma cortisol concentrations, SIV-specific IgG, and expression of genes associated with Type I interferon early in infection. SIV viral RNA set-point was strongly and negatively correlated with survival as expected. Set-point was also associated with expression of interferon-stimulated genes, with CXCR3 expression, and with SIV-specific IgG titers. Poorer immune responses, in turn, were associated with display of sustained aggression and submission. Personality and genotype acted independently as well as in interaction with social condition to affect behavioral responses. Together, the data support an "interactionist" perspective [Eysenck, H.J., 1991. Personality, stress and disease: an interactionist perspective. Psychol. Inquiry 2, 221-232] on disease. Given that an important goal of HIV treatment is to maintain viral set-point as low as possible, our data suggest that supplementing anti-retroviral therapy with behavioral or pharmacologic modulation of other aspects of an organism's functioning might prolong survival, particularly among individuals living under conditions of threat or uncertainty.
Capitanio
John P
JP
California National Primate Research Center, Department of Psychology, University of California, One Shields Avenue, Davis, CA 95616, USA. jpcapitanio@ucdavis.edu
Abel
Kristina
K
Mendoza
Sally P
SP
Blozis
Shelley A
SA
McChesney
Michael B
MB
Cole
Steve W
SW
Mason
William A
WA
D000374:Aggression / Q000502:physiology; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D001522:Behavior, Animal / Q000502:physiology; D004195:Disease Models, Animal; D005838:Genotype; D006854:Hydrocortisone / Q000097:blood; D007109:Immunity / Q000502:physiology*; D007074:Immunoglobulin G / Q000097:blood; D007370:Interferon Type I / Q000235:genetics; D008253:Macaca mulatta; D008297:Male; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000097:blood; D054367:Receptors, CXCR3 / Q000235:genetics; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000235:genetics / Q000276:immunology / Q000523:psychology*; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000276:immunology; D012919:Social Behavior; D013315:Stress, Psychological / Q000276:immunology / Q000503:physiopathology; D019562:Viral Load; D014779:Virus Replication
D000914:Antibodies, Viral; D007074:Immunoglobulin G; D007370:Interferon Type I; D012367:RNA, Viral; D054367:Receptors, CXCR3; D050486:Serotonin Plasma Membrane Transport Proteins; D006854:Hydrocortisone
Primates. 2002 Jul;43(3):169-77
12145398
Psychosom Med. 1998 May-Jun;60(3):235-44
9625208
Clin Immunol. 2003 Sep;108(3):167-74
14499239
J Med Primatol. 2003 Aug;32(4-5):247-64
14498985
Am J Primatol. 2003 Oct;61(2):73-83
14582129
Biol Psychiatry. 2003 Nov 15;54(10):953-9
14625137
Genes Brain Behav. 2003 Dec;2(6):336-40
14653305
Biol Psychiatry. 2003 Dec 15;54(12):1444-56
14675810
J Virol. 2004 Jan;78(2):841-54
14694116
Mol Immunol. 2005 Feb;42(2):251-8
15488612
Am Psychol. 1984 Nov;39(11):1309-14
6507995
J Gen Virol. 1987 Dec;68 ( Pt 12):3183-9
2826656
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6353-7
2548210
J Interferon Res. 1994 Oct;14(5):259-63
7532202
Brain Behav Immun. 1994 Dec;8(4):293-312
7696716
Arch Gen Psychiatry. 1995 Jul;52(7):583-93
7598635
J Immunol. 1998 Jul 15;161(2):610-6
9670934
Semin Immunol. 1998 Oct;10(5):383-90
9799713
Brain Behav Immun. 1998 Dec;12(4):249-71
10080856
Am J Primatol. 1999;47(4):299-320
10206208
J Virol. 1999 Jun;73(6):4829-39
10233944
Brain Behav Immun. 1999 Jun;13(2):138-54
10373278
Am J Primatol. 2005 Mar;65(3):289-94
15772988
Nature. 2005 Apr 28;434(7037):1093-7
15793563
Nature. 2005 Apr 28;434(7037):1148-52
15793562
Curr Drug Targets Infect Disord. 2005 Jun;5(2):95-111
15975016
Scand J Immunol. 2006 Feb;63(2):106-15
16476009
J Virol. 2006 May;80(9):4326-35
16611891
Nat Rev Neurosci. 2006 Jul;7(7):583-90
16791147
Psychosom Med. 1999 Nov-Dec;61(6):842-9
10593637
Am J Psychiatry. 2000 Aug;157(8):1221-8
10910783
AIDS Res Hum Retroviruses. 2001 Feb 10;17(3):243-51
11177407
Blood. 2001 Aug 15;98(4):906-12
11493432
Annu Rev Microbiol. 2001;55:255-81
11544356
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12695-700
11675501
Mol Psychiatry. 2002;7(1):118-22
11803458
J Virol. 2002 Aug;76(16):8433-45
12134046
AIDS Educ Prev. 1995;7(5 Suppl):36-47
8664097
Science. 1996 May 24;272(5265):1167-70
8638160
J Neurochem. 1996 Jun;66(6):2621-4
8632190
J Clin Endocrinol Metab. 1996 Jul;81(7):2601-6
8675584
J Virol. 1997 Jan;71(1):284-90
8985348
J Pers Soc Psychol. 1997 Feb;72(2):320-35
9107003
AIDS. 1998 Jan 1;12(1):1-10
9456249
J Neural Transm (Vienna). 1997;104(11-12):1259-66
9503271
Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4714-9
9539804
Psychol Med. 2002 Aug;32(6):1059-73
12214787